echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Lancet: Phase 1 tumor clinical trial, patients benefit more and more in recent years

    Lancet: Phase 1 tumor clinical trial, patients benefit more and more in recent years

    • Last Update: 2022-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    This article is from NEJM Journal Watch Phase 1 Oncology Trials: Improved Outcomes Over Time
    Phase 1 Oncology Trials: Improving
    Outcomes Over Time Review by William J.



    NEJM Journal Collection

    NEJM Journal Watch, published by NEJM Group, invites internationally renowned physicians to review important papers in the field of medicine and help physicians understand and apply the latest advances
    .

    "NEJM Medical Frontiers" translates several times a week, publishes them on the app and official website, and selects 2-3 articles to be published
    on WeChat.




    Copyright informationThis article was translated, authored or commissioned
    by the Jiahui Medical Research and Education Group (J-Med) and the New England Journal of Medicine (NEJM), which is jointly developed by the New England Journal of Medicine (NEJM).

    The full text of the Chinese translation and the charts contained therein are exclusively authorized
    by NEJM Group.

    If you need to reprint, please leave a message or contact nejmqianyan@nejmqianyan.
    cn
    .

    Unauthorized translation is an infringement and the copyright owner reserves the right to
    pursue legal liability.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.